Prosthetic retina could help counter the effects of AMD and related vision disorders

The loss of eyesight, often caused by retinal degeneration, is a life-altering health issue for many people, especially as they age. But a new development toward a prosthetic retina could help counter conditions that result from problems with this crucial part of the eye. Scientists published their research on a new device, which they tested on tissue from laboratory animals, in the ACS journal Nano Letters.

Yael Hanein and colleagues point out that a growing range of medical devices has become available to treat conditions, including visual impairment, that involve sending sensory signals to the brain. Patients with one type of eye disorder called age-related macular degeneration (AMD), for example, could potentially benefit from such a device, they say. AMD usually affects people age 60 or older who have damage to a specific part of the retina, limiting their vision.

Scientists are trying different approaches to develop an implant that can "see" light and send visual signals to a person's brain, countering the effects of AMD and related vision disorders. But many attempts so far use metallic parts, cumbersome wiring or have low resolution. The researchers, an interdisciplinary team from Tel Aviv University, the Hebrew University of Jerusalem Centers for Nanoscience and Nanotechnology and Newcastle University, wanted to make a more compact device.

The researchers combined semiconductor nanorods and carbon nanotubes to create a wireless, light-sensitive, flexible film that could potentially act in the place of a damaged retina. When they tested it with a chick retina that normally doesn't respond to light, they found that the film absorbed light and, in response, sparked neuronal activity. In comparison with other technologies, the researchers conclude theirs is more durable, flexible and efficient, as well as better able to stimulate neurons.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Small brain-penetrating molecule offers hope for treating aggressive brain tumors